What does Sociedad Química y Minera de Chile do?
Sociedad Química y Minera de Chile S.A., usually called SQM, produces lithium chemicals, iodine, specialty plant nutrients, potassium products, and industrial chemicals. Its Series B American depositary shares trade on the NYSE under SQM, while Series A and B shares trade in Santiago. Its strategic value rests on northern Chilean brines and caliche, chemical-conversion expertise, and global distribution.
A resource company with chemical-market exposure
SQM extracts brines and caliche, then upgrades them into lithium carbonate, lithium hydroxide, iodine, potassium nitrate, and fertilizer blends. Customers buy qualified chemistry, consistency, and reliable logistics—not raw ore alone. SQM’s official corporate profile frames the portfolio around health, food, technology, and clean-energy applications.
| Business line | Representative products | Main demand drivers | Economic role |
|---|---|---|---|
| Lithium and derivatives | Lithium carbonate, lithium hydroxide, spodumene | Electric vehicles, stationary storage, electronics | Largest revenue and profit contributor in Q1 2026 |
| Iodine and derivatives | Iodine and specialty derivatives | X-ray contrast media, pharmaceuticals, nutrition, industrial uses | High-margin diversification outside lithium |
| Specialty plant nutrition | Potassium nitrate and tailored blends | High-value crops, fertigation, yield and quality improvement | Large-volume, globally distributed agricultural franchise |
| Potassium and industrial chemicals | Potassium chloride, potassium sulfate, sodium and potassium nitrates | Agriculture, thermal storage, glass, explosives, industrial processing | Smaller segments that monetize shared resources and infrastructure |
The portfolio diversifies end-market exposure, although lithium can dominate quarterly results. Operations and offices across more than 20 countries make distribution and customer qualification core capabilities.
How does SQM make money, and which business matters most?
SQM sells chemical volumes at market-linked or negotiated prices. Revenue depends on volume, realized price, product mix, freight, and currency. Lithium is most sensitive to battery-chain inventory and new supply; iodine and specialty nutrition follow different demand cycles and can stabilize gross profit.
FY2025 revenue was diversified, but lithium remained the largest engine
Different products have different pricing and margin logic
| Revenue stream | FY2025 operating scale | Pricing logic | Key margin driver |
|---|---|---|---|
| Nova Andino lithium | 233.1 thousand MT LCE sold | Realized chemical prices reflect global lithium conditions and contract mix | Brine concentration, conversion yields, royalties, taxes, and logistics |
| International lithium | 156.4 thousand MT spodumene and 1.6 thousand MT LCE hydroxide sold | Spodumene and refined-product prices; attributable accounting | Mt Holland throughput and Kwinana refinery ramp efficiency |
| Iodine | 14.5 thousand MT sold | Tighter specialty market with negotiated customer relationships | Caliche grade, capacity utilization, seawater supply, and product mix |
| Specialty plant nutrition | 1,012.9 thousand MT sold | Crop economics, regional supply, mix of potassium nitrate and blends | Feedstock costs, formulation mix, freight, and distribution reach |
The FY2025 earnings release shows why gross-profit contribution is more informative than revenue alone: iodine generated 42% of gross profit on 22.8% of revenue, while lithium generated 45% of gross profit on 50.0% of revenue. That mix can reverse quickly when lithium prices move.
What does SQM’s latest quarter show?
The quarter ended March 31, 2026 showed strong operating leverage. Revenue rose 69.8% to $1.76 billion as lithium volume and realized prices improved. Gross profit reached $778.6 million, operating income $720.9 million, and attributable net income $364.7 million.
Lithium supplied most of the acceleration
| Metric | Q1 2026 | Q1 2025 | Interpretation |
|---|---|---|---|
| Revenue | $1,760.1M | $1,036.6M | Higher lithium price and volume drove the 69.8% increase. |
| Gross profit | $778.6M | $304.7M | Gross margin expanded 14.8 percentage points to 44.2%. |
| Operating income | $720.9M | $244.9M | Administrative expense was only 2.8% of revenue. |
| Net income attributable to parent | $364.7M | $137.5M | Q1 2026 diluted earnings were $1.28 per share. |
| Operating cash flow | $862.6M | Not comparable here | Cash conversion exceeded reported net income during the quarter. |
| Property, plant and equipment purchases | $178.4M | Not comparable here | Simple operating cash flow less capex equaled about $684.2M. |
The quarter also changed the near-term operating outlook
SQM sold 69.0 thousand metric tons LCE in Q1 2026, up 25%. Nova Andino sold 62.4 thousand metric tons at roughly $17.8 per kilogram, about 95% above Q1 2025. Management raised 2026 consolidated lithium-volume growth guidance to approximately 15% and estimated global demand could exceed 1.9 million metric tons LCE. The official Q1 2026 earnings package also reported $275.9 million of iodine revenue, $239.0 million of specialty-nutrition revenue, and a 31% decline in potassium volume.
The detailed March 31, 2026 financial statements are important because they reveal both the earnings leverage and the financial obligations behind expansion, including tax expense of $283.9 million and substantial new borrowing during the quarter.
Which turning points explain SQM’s strategy today?
SQM’s model reflects privatization, Salar de Atacama access, international funding, specialty-chemical conversion, and expansion beyond Chile. Cash flows still depend on resource agreements, processing investments, and state relationships.
From Chilean mineral producer to global battery-material supplier
-
1968SQM was incorporated to develop nitrate and iodine resources. The original caliche base still underpins iodine, specialty nutrition, and industrial-chemical economics.
-
1983–1988Privatization shifted SQM into a publicly owned commercial enterprise, establishing the governance and capital-allocation framework that later funded expansion.
-
1993Series B American depositary shares began trading on the NYSE, broadening access to international equity investors and disclosure standards.
-
1994–1999Roughly $300 million was invested in the Salar de Atacama development; lithium carbonate production started in 1996, creating the platform for SQM’s largest modern business.
-
2000–2020Capacity, product quality, and global distribution expanded across lithium, iodine, and specialty nutrients, increasing scale and lowering unit-cost exposure.
-
2021–2025SQM committed major capital to Chilean refining, Australia’s Mt Holland mine and Kwinana refinery, iodine expansion, and the Salar Futuro operating concept.
-
December 2025The Codelco partnership was completed through Nova Andino Litio, aligning future Salar development with Chile’s state copper company and changing the long-term governance and economic-sharing structure.
The Codelco partnership is both continuity and structural change
The creation of Nova Andino Litio is central to the company’s future because it provides a framework for developing lithium in the Salar de Atacama beyond the current contractual period. The official completion announcement states that economic rights began January 1, 2025 and closing occurred December 27, 2025, subject then to a judicial condition. The arrangement may extend resource access, but valuation must incorporate state contributions, taxes, governance, and profit sharing.
Lithium, iodine, and distribution define SQM’s competitive position
SQM’s advantage is a system: high-quality brine and caliche, large conversion plants, qualified products, technical expertise, and global sales. Replicating the chain requires deposits, permits, capital, process knowledge, time, and customer acceptance.
What gives the resource base strategic value?
The Salar de Atacama combines lithium-rich brine, arid conditions, and infrastructure; northern Chilean caliche contains iodine and nitrates. Shared utilities, logistics, and processing create scope economies. Chilean lithium refining capacity reached 210 thousand metric tons LCE in 2024, while Australia adds hard-rock feedstock and jurisdictional diversification.
Which competitors pressure the model?
| Arena | Relevant competitors | SQM position | Competitive pressure |
|---|---|---|---|
| Lithium chemicals | Albemarle, Ganfeng, Tianqi, and Australian hard-rock supply chains | Large brine producer with expanding Australian exposure | New supply, conversion capacity, contract terms, and price competition |
| Iodine | Chilean iodine producers including Cosayach and ACF Minera | SQM estimated a 37% global market share for FY2025 | Capacity additions, medical-demand growth, and customer qualification |
| Specialty plant nutrition | ICL, Haifa, Yara, and regional specialty-fertilizer suppliers | SQM estimated a 39% market share for FY2025 | Crop economics, substitutes, freight, and regional distribution |
| Industrial potassium nitrate | Integrated nitrate and industrial-chemical suppliers | SQM estimated a 13% market share for FY2025 | Project timing, energy-storage demand, and contract concentration |
SQM summarizes market-share estimates and segment economics in its March 2026 corporate presentation. The capabilities are difficult to replicate but not isolating: customers can multi-source, prices transmit global supply, and permits remain essential.
How financially strong is SQM through the commodity cycle?
At March 31, 2026, SQM held $2.83 billion of cash and $1.04 billion of other current financial assets. Equity was $8.22 billion versus $7.56 billion of liabilities, while current and non-current financial liabilities totaled about $5.11 billion before leases. Liquidity is substantial, but so is expansion funding.
Cash flow improved faster than reported earnings
Balance-sheet capacity must be judged beside the project pipeline
| Balance-sheet or capital item | Official period | Amount | Why it matters |
|---|---|---|---|
| Cash and cash equivalents | March 31, 2026 | $2.83B | Provides liquidity for working capital, capex, debt service, and volatility. |
| Other current financial assets | March 31, 2026 | $1.04B | Adds short-duration financial resources beyond cash. |
| Current and non-current financial liabilities | March 31, 2026 | $5.11B | Raises interest and refinancing sensitivity as expansion continues. |
| Property, plant and equipment | March 31, 2026 | $4.92B | Shows the capital base required for extraction and conversion. |
| Inventory | March 31, 2026 | $1.88B | Creates working-capital exposure when prices or demand change. |
| New long-term loans | Q1 2026 | $600.0M | Funded liquidity and investment while increasing gross obligations. |
| Loan repayments | Q1 2026 | $218.0M | Demonstrates active liability management during the quarter. |
Capital allocation balances growth, state payments, debt, and distributions. SQM spent more than $1.3 billion on capital projects in 2024 across lithium, iodine infrastructure, and Australia. Its 2024 annual report shows the trade-off: projects can extend capacity and diversify resources, but consume cash before full utilization and expose returns to ramp-up and commodity-price risk.
Who owns SQM stock, and why does control matter?
Series A and B shares have equal economics but different board-election rights: Series A elects seven of eight directors and Series B elects one. NYSE ADRs represent Series B shares, so economic exposure and voting influence are not equivalent.
The shareholder base combines strategic blocks and public-market capital
| Holder or group | Reported ownership | Source period | Governance relevance |
|---|---|---|---|
| Pampa Group | 26% | December 31, 2025 | Large strategic block; share-class composition matters for director influence. |
| Tianqi | 22% | December 31, 2025 | Strategic lithium-industry shareholder with significant economic exposure. |
| BNY Mellon ADR registered position | 17% | December 31, 2025 | Represents deposited Series B shares held for multiple ADR investors. |
| Chilean pension funds | 13% | December 31, 2025 | Domestic institutional capital can influence governance expectations. |
| Kowa Group and others | 22% combined | December 31, 2025 | Includes a 2% Kowa position and a broad 20% residual public float. |
Share classes change how ownership should be interpreted
SQM’s official share-capital description explains that Series A and Series B shares have the same dividend and economic rights but different director-election rights. The ownership mix also makes capital allocation politically and strategically sensitive: dividends, expansion spending, and the Codelco partnership affect local institutions, global ADR investors, and strategic shareholders differently.
What opportunities could expand SQM’s cash flows?
The opportunity is profitable volume growth, not merely higher lithium prices. Chilean brines, the Australian hard-rock chain, iodine expansion, and specialty-nutrition distribution each offer growth with different timetables and risks.
Lithium growth now spans Chile and Australia
Management estimated 2026 global lithium demand could exceed 1.9 million metric tons LCE. Mt Holland diversifies feedstock; Kwinana adds refined hydroxide; Salar Futuro targets improved recovery in Chile. Returns still must cover royalties, taxes, partner economics, and capital.
Iodine and specialty nutrition provide a second growth axis
The best outcome pairs lithium growth with steadier iodine and nutrition cash flows. The weaker outcome is spending ahead of end-market absorption.
What risks could change SQM’s outlook?
SQM’s risks compound. Lower lithium prices compress margin and project funding; regulatory delays can postpone volume as global supply rises; operating problems can then worsen cash conversion. The analysis should follow these financial linkages.
Commodity concentration remains the first-order risk
Regulation, water, execution, and financing can alter returns
| Risk | Financial transmission | Current factual anchor | What to monitor |
|---|---|---|---|
| Lithium price volatility | Revenue, gross margin, inventory values, and project returns | Q1 2026 Nova Andino realized price was about 95% above Q1 2025 | Realized price per kilogram, contract mix, and global supply additions |
| State and partnership economics | Taxes, contributions, attributable earnings, and terminal cash flows | Nova Andino generated more than $530M of contributions to the Chilean state in Q1 2026 | Codelco governance, state take, judicial conditions, and 2031–2060 framework |
| Permitting and water constraints | Capacity timing, remediation costs, and license to operate | Salar Futuro documentation and a major iodine seawater pipeline remained execution items in 2026 | Approvals, extraction limits, environmental commitments, and commissioning |
| Australian ramp-up | Utilization, unit cost, depreciation, and cash conversion | Mt Holland was at full capacity; Kwinana targeted nameplate operation in 2027 | Recovery, product qualification, throughput, and refinery operating cost |
| Leverage and interest cost | Net income, refinancing flexibility, and shareholder distributions | Financial liabilities were approximately $5.11B at March 31, 2026 | Net debt, maturities, rates, capex, and free cash flow |
| Portfolio imbalance | Dependence on one commodity cycle | Lithium supplied 67.4% of Q1 2026 revenue and 75% of gross profit contribution | Iodine and specialty-nutrition margin contribution versus lithium |
Do not extrapolate Q1 2026 margins as permanent. Forecasts should stress lower prices, project delays, higher state payments, and elevated capex.
What is the key takeaway for an SQM valuation?
SQM is a cyclical, capital-intensive chemical producer with scarce-resource advantages—not a simple lithium-volume story. A DCF needs separate price, volume, margin, and capital assumptions by segment, plus Codelco-linked economics, taxes, Australian ramp-up costs, and resource duration.
Which KPIs belong in the model?
The favorable case combines durable Salar access, disciplined growth, Australian integration, and self-funded investment. The pressure case combines lower prices, slow ramps, higher state economics, and sustained capex.
The key sensitivity is normalized cash margin after royalties, taxes, partner economics, and capex. In Q1 2026, 69.8% revenue growth produced 155.6% gross-profit growth and 165.2% attributable-net-income growth. FY2025’s 29.6% gross margin is a useful counterweight to that rebound quarter.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.